These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2275478)

  • 21. [Infection as a cause of multiple organ failure. Definition, pathophysiology and diagnostic parameters].
    Schuster HP
    Anasth Intensivther Notfallmed; 1989 Aug; 24(4):206-11. PubMed ID: 2683847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment with monoclonal anti-endotoxin antibodies of patients with sepsis caused by Gram-negative bacteria].
    Ned Tijdschr Geneeskd; 1991 Jul; 135(28):1289-91. PubMed ID: 1861770
    [No Abstract]   [Full Text] [Related]  

  • 23. Epidemiology, pathophysiology and clinical presentation of gram-negative sepsis.
    Hazinski MF; Iberti TJ; MacIntyre NR; Parker MM; Tribett D; Prion S; Chmel H
    Am J Crit Care; 1993 May; 2(3):224-35; quiz 236-7. PubMed ID: 8364674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The therapeutic challenge of Gram-negative sepsis: prolonging the lifespan of a scarce resource.
    Richards GA
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():18-22. PubMed ID: 16209702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to deal with sepsis and bacteremia.
    Rutledge KA; McDonald HP
    Urology; 1985 Jul; 26(1 Suppl):34-7. PubMed ID: 4012999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basic therapeutic requirements in the treatment of sepsis in acute renal failure.
    Cambi V; David S
    Nephrol Dial Transplant; 1994; 9 Suppl 4():183-6. PubMed ID: 7800255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new method for removing endotoxin from plasma using hemocompatible affinity chromatography technology, applicable for extracorporeal treatment of septic patients.
    Amoureux MC; Hegyi E; Le D; Grandics P; Tong H; Szathmary S
    J Endotoxin Res; 2004; 10(2):85-95. PubMed ID: 15119999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Infection caused by gram-positive and gram-negative bacteria. A comparative study].
    Ruhnke-Trautmann M; Trautmann M; Brückner O; Weinke T; Wagner J
    Fortschr Med; 1989 Jul; 107(22):477-80. PubMed ID: 2793023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Bacterial endotoxins and their effects].
    Bertók L
    Orv Hetil; 1998 Aug; 139(33):1947-53. PubMed ID: 9734211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacotherapy of sepsis].
    Guzzo I; Morabito S; Stucchi R; Poli G; Fumagalli R
    G Ital Nefrol; 2006; 23 Suppl 36():S79-86. PubMed ID: 17068734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy in the management of sepsis.
    Sikora JP
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):317-24. PubMed ID: 12455865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Present possibilities of therapy of septic shock in surgical patients].
    Vyhnánek F; Lochmann O
    Cesk Epidemiol Mikrobiol Imunol; 1992 Sep; 42(3):105-15. PubMed ID: 1339601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic interventions aimed at preventing the biologic effects of endotoxin.
    Sable CA; Wispelwey B
    Infect Dis Clin North Am; 1991 Dec; 5(4):883-98. PubMed ID: 1783774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Projected impact of monoclonal anti-endotoxin antibody therapy.
    Bates DW; Lee TH
    Arch Intern Med; 1994 Jun; 154(11):1241-9. PubMed ID: 8203991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current concepts in the pathogenesis and treatment of abortion and septic shock. II. The physiopathological bases and outlook in the management of septic shock].
    Figueroa Damian R; Arredondo García JL
    Ginecol Obstet Mex; 1993 Dec; 61():337-43. PubMed ID: 8119603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endotoxin release after antibiotic treatment and its potential pathogenetic role in coagulative disorders of patients with gram-negative sepsis.
    Miragliotta G
    J Chemother; 1991 Jan; 3 Suppl 1():69-72. PubMed ID: 12041790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Septic shock; current pathogenetic concepts from a clinical perspective.
    Tsiotou AG; Sakorafas GH; Anagnostopoulos G; Bramis J
    Med Sci Monit; 2005 Mar; 11(3):RA76-85. PubMed ID: 15735579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relationship between gut-derived endotoxemia and tumor necrosis factor, neopterin: experimental and clinical studies.
    Sheng Z; Yao Y; Yu Y
    Chin Med J (Engl); 1997 Jan; 110(1):30-5. PubMed ID: 9594318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.